Skip to main content

Month: June 2024

Orbit Beyond has Acquired a Majority control in stock of Mayex USA, Inc (OTC:MAYX)

EDISON, N.J., June 18, 2024 (GLOBE NEWSWIRE) — Orbit Beyond Inc a lunar transportation, infrastructure, and exploration services company today announced that it has acquired a majority of the stock of Mayex USA, Inc (OTC:MAYX) which is a public vehicle. With the purchase of MAYX, Orbit Beyond believes that it has achieved a significant milestone for the company, providing a foundation for its upcoming endeavors. CEO Siba Padhi states, “Over the past few years we have been working on securing strategic partnerships, with the goal of becoming a predominant player in the Space Economy. We recognize the importance of not only successfully landing on the moon but also being a part of the Lunar infrastructure market” Orbit Beyond is one of 14 companies under NASA CLPS program. Driven by the rise in space commercialization and the development...

Continue reading

Vishay Intertechnology Honored With 2023 Supply Chain Excellence Award by Continental Automotive (Changchun) Co., Ltd.

MALVERN, Pa., June 18, 2024 (GLOBE NEWSWIRE) — Vishay Intertechnology, Inc. (NYSE: VSH) today announced that the company has received a 2023 Supply Chain Excellence Award from Continental Automotive (Changchun) Co., Ltd, the R&D and production site of Continental AG, a Fortune 500 company, in Changchun. The award recognizes Vishay’s outstanding contributions to Continental Automotive (Changchun), in particular its fast response times and high quality service, with the flexibility to adapt to urgent order changes. Continental Automotive (Changchun) researches, develops, and manufactures automotive electronic components for the Internet of Vehicles (IoV), smart mobility, safety systems, and more. The site’s customers include nearly all the Tier-1 OEMs in China, and it exports products to more than 20 countries and regions. “Receiving...

Continue reading

Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in Brazil

Brazil is the 9th largest economy in the world with more than 21 million people suffering from chronic back pain An estimated 4-5 million epidural anesthesia procedures are performed annually in Brazil; potential to expand this addressable market due to CompuFlo’s technological advantages ROSELAND, N.J., June 18, 2024 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, announces that it has received regulatory approval from Brazil’s National Health Surveillance Agency (ANVISA) to market and sell its CompuFlo® Epidural System in Brazil. The approval includes the lumbar, thoracic, and cervical-thoracic junction of the spine. The CompuFlo® Epidural System, known for its ability to significantly reduce the morbidity...

Continue reading

SM2 Capital Partners Supports Paul Rivett’s Vision and Agrees to Exchange its Shares in Fortress for shares in The Western Investment Company

Western has Secured Agreements in Aggregate to Purchase 98.4% of the Total Shares Outstanding in Fortress Conditional Upon the Successful Completion of the Transaction CALGARY, Alberta, June 18, 2024 (GLOBE NEWSWIRE) — SM2 Holdings Ltd. (“SM2 Capital”), the founder of Fortress Insurance Company, has made the strategic decision to sells its entire 28.45% stake in Fortress Insurance Company (“Fortress”) valued at $5.2 million to The Western Investment Company of Canada Limited (TSXV: WI) (“Western”) upon close of the proposed transaction previously announced on March 22, 2024 (the “Transaction”). SM2 Capital will receive the vast majority of its compensation as shares in Western representing up to 19% of the single voting common shares outstanding in Western at the close of the Transaction, with the remaining compensation settled...

Continue reading

Dresner Partners Advised Absolute Aesthetics Rejuvenation and Laser Center on Its Sale to DermCare Management LLC

CHICAGO, June 18, 2024 (GLOBE NEWSWIRE) — Dresner Partners, an award-winning, FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised Absolute Aesthetics Rejuvenation and Laser Center on its sale to DermCare® Management LLC. Financial terms of the transaction were not disclosed. Plantation, Florida-based Absolute Aesthetics Rejuvenation and Laser Center offers a wide range of aesthetic services, including dermal fillers, neurotoxin injections, laser treatments, body contouring, facials, and much more. Its services are designed to meet the unique needs of each patient. Hollywood, Florida-based DermCare Management, a portfolio company of Hildred Capital Management, is a dermatology practice management company founded on the principle of merging seasoned medical professionals...

Continue reading

GlycoProteMim Featured in Stonegate Healthcare’s Latest Anti-Aging Research Report

VANCOUVER, British Columbia, June 18, 2024 (GLOBE NEWSWIRE) — Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) is pleased to announce that its innovative anti-aging ingredient, GlycoProteMim™, has been featured in Stonegate Healthcare’s newly published research report, “Novel Treatments for Age-Related Skin Problems.” The report provides an in-depth analysis of the latest advancements in the $12.5 billion anti-aging skincare market. The research highlights GlycoProteMim alongside other prominent active ingredients such as OneSkin’s OS-01, Sisley Paris’ Soy Peptides, SK-II’s Pitera™, and SkinMedica’s TNS Advanced Serum. GlycoProteMim is recognized for its unique approach to skin rejuvenation, addressing both surface-level appearance and underlying cellular mechanisms, making...

Continue reading

ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024

18 JUNE 2024 NORTHERN 3 VCT PLC ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024 Northern 3 VCT PLC is a Venture Capital Trust (VCT) managed by Mercia Fund Management Limited. It invests mainly in unquoted venture capital holdings and aims to provide long-term tax-free returns to shareholders through a combination of dividend yield and capital growth. Financial highlights (comparative figures as at 31 March 2023):    Year ended Year ended    31 March 31 March    2024 2023       Net assets   £122.5m £113.0m       Net asset value per share   89.3p 91.6p       Return per share      Revenue   1.1p (0.1)pCapital   1.1p (1.5)pTotal   2.2p (1.6)p       Dividend per share declared in respect of the period      Interim dividend   2.0p 2.0pProposed final dividend   2.2p 2.5pTotal   4.2p...

Continue reading

ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024

18 JUNE 2024 NORTHERN VENTURE TRUST PLC ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024 Northern Venture Trust PLC is a Venture Capital Trust (VCT) advised by Mercia Fund Management Limited. The trust was one of the first VCTs launched on the London Stock Exchange in 1995. It invests mainly in unquoted venture capital holdings and aims to provide high long-term tax-free returns to shareholders through a combination of dividend yield and capital growth. Financial highlights (comparative figures as at 31 March 2023):    12m period ended Unaudited 12m period ended 18m period ended    31 March 31 March 31 March    2024 2023 2023         Net assets   £114.8m £102.5m £102.5m         Net asset value per share   60.3p 62.1p 62.1p         Return per share        Revenue   0.6p (0.3)p (0.3)pCapital   1.2p (2.1)p (5.7)pTotal   1.8p (2.4)p (6.0)p         Dividend...

Continue reading

ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024

18 JUNE 2024 NORTHERN 2 VCT PLC ANNUAL FINANCIAL REPORT FOR THE YEAR ENDED 31 MARCH 2024 Northern 2 VCT PLC is a Venture Capital Trust (VCT) managed by Mercia Fund Management Limited. It invests mainly in unquoted venture capital holdings in growing UK companies and aims to provide long-term tax-free returns to shareholders through a combination of dividend yield and capital growth. Financial highlights (comparative figures as at 31 March 2023):    Year ended Year ended    31 March 31 March    2024 2023       Net assets   £119.5m £109.6m       Net asset value per share 57.3p 59.0p       Return per share      Revenue   0.8p (0.2)pCapital   0.6p (1.7)pTotal   1.4p (1.9)p       Dividend per share declared in respect of the period    Interim dividend   1.8p 2.0pProposed final dividend 1.2p...

Continue reading

21Shares Announces the Hire of Federico Brokate, Highlighting the Firm’s Growth in the U.S. Market

Brokate will join 21Shares as Head of the U.S. Business as U.S. investors continue to express interest in and excitement for crypto-asset exchange traded funds (ETFs) New York, June 18, 2024 – 21Shares US LLC (“21Shares”), an affiliate of 21Shares AG, one of the world’s largest issuers of crypto exchange traded funds (ETFs), today announced the appointment of Federico Brokate as VP, Head of U.S. Business to support the expansion of 21Shares’ U.S. market presence. The appointment of Mr. Brokate coincides with the continued growth of 21Shares’ U.S. business, which now includes a lineup of six total crypto-asset ETFs, over $3.2bn in assets under management and nearly 50 full-time employees.Mr. Brokate most recently served as Director of America’s iShares Business Strategy for BlackRock where he developed and executed iShares’...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.